Literature DB >> 11122595

Drug labeling revisions-guaranteed to fail?

R L Woosley1.   

Abstract

Mesh：

Year:  2000        PMID： 11122595     DOI： 10.1001/jama.284.23.3047

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Limited adherence to safety instructions in drug leaflets.

Authors:  H J Derijks; G H P De Koning; A K Mantel-Teeuwisse; A C G Egberts
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

Review 2.  Impact of safety-related regulatory action on clinical practice: a systematic review.

Authors:  Sigrid Piening; Flora M Haaijer-Ruskamp; Jonie T N de Vries; Menno E van der Elst; Pieter A de Graeff; Sabine M J M Straus; Peter G M Mol
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

3.  A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.

Authors:  Peter G M Mol; Sabine M J M Straus; Sigrid Piening; Jonie T N de Vries; Pieter A de Graeff; Flora M Haaijer-Ruskamp
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

Review 4.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

5.  Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain.

Authors:  Gabriel Sanfélix-Gimeno; Pedro Cervera-Casino; Salvador Peiró; Beatriz González López-Valcarcel; Amparo Blázquez; Teresa Barbera
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  An Interactive User Interface for Drug Labeling to Improve Readability and Decision-Making.

Authors:  Hamed Abedtash; Jon D Duke
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

7.  Interrupting drug therapy in the perioperative period.

Authors:  David W Noble; John Webster
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram.

Authors:  Kevin J Friesen; Shawn C Bugden
Journal:  Drug Healthc Patient Saf       Date:  2015-08-19

9.  Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS).

Authors:  Keith B Hoffman; Andrea R Demakas; Mo Dimbil; Nicholas P Tatonetti; Colin B Erdman
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

10.  Balancing commercial and public interests.

Authors:  Curt D Furberg; Mark A Hall; Mary Ann Sevick
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.